Interventional Cardiology Devices Market Top Players - Medtronic (US), Boston Scientific Corporation (US), Abbott (US), Edward Lifescinces Corporation (US), Cardinal Health (US).

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Interventional Cardiology Devices Market- (By Product (Angioplasty Balloons (Old/Normal Balloons, Drug-eluting Balloons, Cutting and Scoring Balloons), Angioplasty Stents (Drug-eluting Stents, Bare-metal Stents, Bioabsorbable Stents), Structural Heart Devics (Aortic Valve Therapy Devices, Other Therapy Devices (Mitral valve, pulmonary valve and tricuspid valve and left atrial appendage therapy devices)), Catheters (Angiography Catheters, Guiding Catheters, IVUS/OCT Catheters), Plaque Modification Devices (Atherectomy Devices, Thrombectomy Devices), Hemodynamic Flow Alteration Devices (Embolic Protection Devices, Chronic Total Occlusion Devices), Other Devices (Guidewires, Vascular Closure Devices, Introducer Sheaths, Hemostasis Valves, Balloon Inflation Devices)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."

According to the latest research by InsightAce Analytic, the Global Interventional Cardiology Devices Market is valued at US$ 17.69 Bn in 2022, and it is expected to reach US$ 33.46 Bn by 2031, with a CAGR of 7.5% during a forecast period of 2023-2031.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2012

Interventional cardiology devices are specialized medical instruments designed to diagnose and treat cardiovascular conditions through minimally invasive procedures. These devices are essential in interventional cardiology, a field focused on addressing heart diseases using catheter-based techniques rather than traditional open-heart surgery. According to recent studies, heart attacks and strokes account for over 80% of deaths related to cardiovascular diseases, with a significant portion of these fatalities occurring before the age of 70. Major behavioral risk factors contributing to cardiovascular disease and stroke include poor diet, smoking, physical inactivity, and excessive alcohol consumption.

Additionally, obesity and high blood pressure are commonly associated with an increased risk of cardiovascular disease. These factors are expected to drive the growth of the interventional cardiology device market during the forecast period. Other risk factors such as diabetes and hypertension also contribute to the rising demand for these devices, as diabetes, in particular, is closely linked to conditions that elevate the risk of coronary heart disease. Chronic high blood sugar can damage blood vessels, which are crucial for heart function, further exacerbating cardiovascular risks.

List of Prominent Players in the Interventional Cardiology Devices Market:
• Medtronic (US),
• Boston Scientific Corporation (US),
• Abbott (US),
• Edward Lifescinces Corporation (US),
• Cardinal Health (US),
• iVascular (Spain),
• Becton, Dickinson, and Company (US),
• B. Braun Melsungen (Germany),
• Terumo Corporation (Japan),
• Biosensors International Group (Singapore),
• BIOTRONIK SE & Co. KG (Germany).

Market Dynamics:
Drivers-
Cardiovascular diseases, such as valvular defects and atrial stenosis, are widespread in developing countries like China, India, and Brazil, driving a significant demand for interventional cardiology devices. To meet this growing need, leading medical device manufacturers are heavily investing in research and development to create and launch innovative products tailored to these markets. Additionally, key industry players are forming strategic collaborations to conduct various clinical trials on interventional devices. The market is also expected to see further growth as regulatory bodies in developing countries increasingly approve these devices from domestic manufacturers.

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-02

Challenges:
The market experienced significant disruption in 2020 due to the COVID-19 pandemic, which severely impacted elective surgical procedures worldwide. As healthcare facilities focused on managing the surge of COVID-19 patients, treatments for structural and coronary heart diseases were postponed. However, by 2021, there was a marked increase in elective and interventional surgeries, including coronary procedures, across various countries. Furthermore, the post-pandemic preference for interventional therapies, owing to their non-invasive nature and enhanced infection control, is expected to drive continued market growth.

Regional Trends:
The North American market for interventional cardiology devices is anticipated to capture the largest revenue share. This dominance is attributed to the high prevalence of coronary heart disease and the increasing emphasis by major manufacturers on innovative technologies. The market's growth is further fueled by the rising incidence of coronary conditions being diagnosed and treated. In 2021, Europe also held a significant market share, driven by the availability of affordable interventional devices.

Recent Developments:
• In Feb 2023, Abbott agreed to buy Cardiovascular Systems (CSI), a business that makes medical devices, in a deal worth about $890 Bn. Interventional treatment devices for people with peripheral and coronary artery disease were made by CSI and sold to patients. The devices were made for atherectomy, which is a minimally invasive way to treat plaque buildup in the vessels that can stop blood flow.
• In March 2021, The multinational medical technology company Medtronic recently declared the commercialization of their Chameleon Percutaneous Transluminal Angioplasty (PTA) balloon catheter in various nations, including Italy, Portugal, South Africa, and Turkey. The gadget facilitates the administration of diagnostic or therapeutic fluids by means of the integrated injection port located near the balloon.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2012

Segmentation of Interventional Cardiology Devices Market-
By Product
• Angioplasty Balloons
o Old/Normal Balloons
o Drug-eluting Balloons
o Cutting and Scoring Balloons
• Angioplasty Stents
o Drug-eluting Stents
o Bare-metal Stents
o Bioabsorbable Stents
• Structural Heart Devics
o Aortic Valve Therapy Devices
o Other Therapy Devices (Mitral valve, pulmonary valve and tricuspid valve and left atrial appendage therapy devices)
• Catheters
o Angiography Catheters
o Guiding Catheters
o IVUS/OCT Catheters
• Plaque Modification Devices
o Atherectomy Devices
o Thrombectomy Devices
• Hemodynamic Flow Alteration Devices
o Embolic Protection Devices
o Chronic Total Occlusion Devices
• Other Devices
o Guidewires
o Vascular Closure Devices
o Introducer Sheaths
o Hemostasis Valves
o Balloon Inflation Devices
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

Read Overview Report- https://www.insightaceanalytic.com/report/interventional-cardiology-devices-market/2012

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.